Efficacy of Morosil® on weight loss in overweight but otherwise healthy men and women. A randomised double-blind placebo-controlled study.

Phase 3

Completed

• Conditions: Overweight; Diet and Nutrition - Obesity; Alternative and Complementary Medicine - Other alternative and complementary medicine

• Registration Number: ACTRN12618001215213
• Lead Sponsor: RDC Global Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-07-19
• Study Completion: 2020-06-06
• Last Update Posted: 20 September 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Males and females aged between 20 and 65 years
BMI >25 - <35 kg/m2
Not currently taking any medication, supplements or functional foods targeted at weight loss and/ appetite control
Participants who agree to not use other treatment including diets for weight loss and/or appetite control during the study
Participants agreement to participation in the study and investigational schedule
Written informed consent from the participant

Exclusion Criteria

Clinically significant medical conditions including, but not limited to, cardiovascular, neurological, psychiatric, renal, gastrointestinal, immunological, endocrine (including uncontrolled diabetes or thyroid disease) or haematological abnormalities that are uncontrolled
Significant variation in weight (more than 10%) in the past 3 months
Participation in another weight loss clinical trial in the past 3 months
No current use of prescription medications except the oral contraceptive pill if female
Females attempting conception, currently pregnant or breastfeeding
Alcohol consumption of above 2 standards drinks daily, drug use, or other confounding conditions
Malignancy or treatment for malignancy within the previous 2 years
Elite or training Athletes
Smokers
Shift workers/unusual sleep and/or dietary patterns
Excessive caffeine intake (>4 caffeinated drinks daily)
Allergic to any of the ingredients in active or placebo formula
No current use of weight loss supplements or medication

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
body weight measured via scales [Baseline, month 1, 2, 3, 4, 5 and 6 post commencement of intervention ]